These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22694259)

  • 1. Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature.
    Morshedi RG; Bettis DI; Moshirfar M; Vitale AT
    Ocul Immunol Inflamm; 2012 Aug; 20(4):266-72. PubMed ID: 22694259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
    Wefers Bettink-Remeijer M; Brouwers K; van Langenhove L; De Waard PW; Missotten TO; Martinez Ciriano JP; Van Aken E
    Eye (Lond); 2009 Dec; 23(12):2260-2. PubMed ID: 19851342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral acute iris transillumination.
    Tugal-Tutkun I; Onal S; Garip A; Taskapili M; Kazokoglu H; Kadayifcilar S; Kestelyn P
    Arch Ophthalmol; 2011 Oct; 129(10):1312-9. PubMed ID: 21987674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral acute iris transillumination (BAIT) initially misdiagnosed as acute iridocyclitis.
    Gonul S; Bozkurt B
    Arq Bras Oftalmol; 2015; 78(2):115-7. PubMed ID: 25945534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Moxiflaxin and iris transillumination].
    Broens A; Collignon N
    Rev Med Liege; 2016 Jul; 71(7-8):321-323. PubMed ID: 28383838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report.
    Rivera-Valdivia N; Arteaga-Rivera K; Reyes-Guanes J; Neira-Segura N; de-la-Torre A
    J Med Case Rep; 2021 Sep; 15(1):462. PubMed ID: 34537056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
    Lončarić K; Tadić R; Radmilović M; Vatavuk Z
    Semin Ophthalmol; 2023 Apr; 38(3):312-315. PubMed ID: 36653737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
    Willermain F; Deflorenne C; Bouffioux C; Janssens X; Koch P; Caspers L
    Eye (Lond); 2010 Aug; 24(8):1419; author reply 1419-20. PubMed ID: 20379213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Moxifloxacin and iris transillumination].
    Broens A; Collignon N
    Rev Med Liege; 2015 Dec; 70(12):606-8. PubMed ID: 26867304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe pseudouveitis associated with moxifloxacin therapy].
    Duncombe A; Gueudry J; Massy N; Chapuzet C; Gueit I; Muraine M
    J Fr Ophtalmol; 2013 Feb; 36(2):146-50. PubMed ID: 23200166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update.
    Tuğal-Tutkun İ; Altan Ç
    Turk J Ophthalmol; 2022 Oct; 52(5):342-347. PubMed ID: 36317812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases.
    Walter K; Tyler ME
    Cornea; 2006 Aug; 25(7):855-7. PubMed ID: 17068466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracameral moxifloxacin: in vitro safety on human ocular cells.
    Kernt M; Neubauer AS; Liegl RG; Lackerbauer CA; Eibl KH; Alge CS; Ulbig MW; A AK
    Cornea; 2009 Jun; 28(5):553-61. PubMed ID: 19421040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy and antibiotics: a case report.
    Reti IM; Davydow DS
    J ECT; 2007 Dec; 23(4):289-90. PubMed ID: 18090707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral acute iris depigmentation and bilateral acute iris transillumination syndrome.
    Rueda-Rueda T; Sánchez-Vicente LJ; Moruno-Rodríguez A; Monge-Esquivel J; Muñoz-Morales A; López-Herrero F
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jul; 94(7):355-358. PubMed ID: 30876733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
    Chang CM; Lee NY; Lee HC; Lee IW; Wu CJ; Lin YS; Ko WC
    Ann Pharmacother; 2008 Apr; 42(4):580-3. PubMed ID: 18349304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral acute iris transillumination following systemic administration of antibiotics.
    Tranos P; Lokovitis E; Masselos S; Kozeis N; Triantafylla M; Markomichelakis N
    Eye (Lond); 2018 Jul; 32(7):1190-1196. PubMed ID: 29497133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.
    Costa FV; Silva AGE; Pedroso LA; Biancardi AL; Curi ALL
    Arq Bras Oftalmol; 2024; 87(4):e2023. PubMed ID: 38656031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute iris depigmentation following systemic moxifloxacin.
    Nascimento HM; Sousa JM; Campos MS; Belfort R
    Clinics (Sao Paulo); 2013 Jul; 68(7):899-900. PubMed ID: 23917650
    [No Abstract]   [Full Text] [Related]  

  • 20. Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis.
    Hadley JA; Mösges R; Desrosiers M; Haverstock D; van Veenhuyzen D; Herman-Gnjidic Z
    Laryngoscope; 2010 May; 120(5):1057-62. PubMed ID: 20422704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.